SPECIFICITY OF HETEROANTISERA DEVELOPED AGAINST PURIFIED POPULATIONS OF INTACT MURINE OVARIAN-CARCINOMA CELLS

被引:6
作者
BAST, RC
KNAPP, RC
DONAHUE, VC
THURSTON, JG
MITCHELL, AK
FEENEY, M
SCHLOSSMAN, SF
机构
[1] SIDNEY FARBER CANC INST,DIV GYNECOL,BOSTON,MA 02115
[2] BOSTON HOSP WOMEN,DIV GYNECOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,JOINT CTR RADIAT THERAPY,BOSTON,MA 02115
关键词
D O I
10.1093/jnci/64.2.365
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:365 / 372
页数:8
相关论文
共 12 条
[1]  
BAST RC, 1979, J IMMUNOL, V123, P1945
[2]   LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY [J].
BOLTON, AE ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1973, 133 (03) :529-538
[3]  
FEKETE E, 1952, CANCER RES, V12, P438
[4]  
FELDMAN GB, 1972, CANCER RES, V32, P1663
[5]  
FELDMAN GB, 1975, CANCER RES, V35, P325
[6]   CORYNEBACTERIUM-PARVUM AS AN IMMUNOTHERAPEUTIC AGENT IN AN OVARIAN CANCER MODEL [J].
KNAPP, RC ;
BERKOWITZ, RS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1977, 128 (07) :782-786
[7]   CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J].
KOHLER, G ;
MILSTEIN, C .
NATURE, 1975, 256 (5517) :495-497
[8]   I125 PROTEIN-A - APPLICATIONS TO QUANTITATIVE-DETERMINATION OF FLUID PHASE AND CELL-BOUND IGG [J].
LANGONE, JJ ;
BOYLE, MDP ;
BORSOS, T .
JOURNAL OF IMMUNOLOGICAL METHODS, 1977, 18 (3-4) :281-293
[9]  
ORDER SE, 1973, CANCER, V32, P573, DOI 10.1002/1097-0142(197309)32:3<573::AID-CNCR2820320309>3.0.CO
[10]  
2-4